Texas Center for Cancer Nanomedicine
University of Texas Health Science Center
Center Overview
The Texas Center for Cancer Nanomedicine is developing and applying a diverse array of nanoplatforms for new therapeutics, methodologies for reliable monitoring of therapeutic efficacy, early detection approaches from biological fluids and advances in imaging, and cancer-prevention protocols for ovarian and pancreatic cancers.
Center Investigators
David G. Gorenstein, Ph.D.
Principal Investigator
Mauro Ferrari, Ph.D.
Principal Investigator
Anil Sood, M.D.
Principal Investigator
Gabriel Lopez-Berestein, M.D.
Principal Investigator
Affiliated Institutions
Projects
- Project 1: Multistage Vectors for Ovarian Cancer Therapeutics
- Project 2: Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature
- Project 3: Nanotechnology Platforms for the Prevention and Personalized Therapy of Pancreatic Adenocarcinoma
- Project 4: Multifunctional Nanoassemblies for Ligand-Directed Imaging and Therapy of Endocrine Pancreatic Tumors
Cores
- Core A: Biomathematics
- Core B: Biomolecular Targeting
- Core C: Nanoengineering


Centers of Cancer Nanotechnology Excellence (CCNEs)